Correlation Between Ginkgo Bioworks and Neurosense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Neurosense Therapeutics, you can compare the effects of market volatilities on Ginkgo Bioworks and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Neurosense Therapeutics.

Diversification Opportunities for Ginkgo Bioworks and Neurosense Therapeutics

-0.34

Correlation Coefficient

Ginkgo Bioworks  Neurosense Therapeutics

Very good diversification

The 3 months correlation between Ginkgo and Neurosense is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Ginkgo Bioworks and Neurosense Therapeutics

Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to under-perform the Neurosense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ginkgo Bioworks Holdings is 1.19 times less risky than Neurosense Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Neurosense Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  125.00  in Neurosense Therapeutics on September 14, 2024 and sell it today you would lose (39.00) from holding Neurosense Therapeutics or give up 31.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ginkgo Bioworks Holdings  vs.  Neurosense Therapeutics

Ginkgo Bioworks Holdings

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point.

Neurosense Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurosense Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Ginkgo Bioworks and Neurosense Therapeutics

The main advantage of trading using opposite Ginkgo Bioworks and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.

The idea behind Ginkgo Bioworks Holdings and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.